Anzeige
Mehr »
Login
Samstag, 25.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0REAW | ISIN: SE0002245548 | Ticker-Symbol: N/A
Frankfurt
01.10.24
17:36 Uhr
0,012 Euro
0,000
0,00 %
1-Jahres-Chart  (nicht börsennotiert)
KOPY GOLDFIELDS AB Chart 1 Jahr
GlobeNewswire (Europe)
101 Leser
Artikel bewerten:
(0)

Kopy Goldfields: Kopy Goldfields AB (publ) applies for delisting of its shares from Nasdaq First North Growth Market

Finanznachrichten News

The annual general meeting of Kopy Goldfields (publ) ("Kopy" or the "Company") resolved on 27 June 2024 on voluntary redemption of shares and on 1 August 2024 Kopy published the outcome of the redemption procedure, which was later supplemented by additional information on the Company's website on 20 August 2024, where shareholders holding approximately 9.43% of the shares accepted and requested to redeem their shares. In light of this, the Company's Board of Directors has applied for delisting of the Company's shares from Nasdaq First North Growth Market in Stockholm ("Nasdaq First North").

On 24 May 2024, Kopy published the Board of Directors' proposal to the annual general meeting regarding the reduction of the share capital for repayment to shareholders through withdrawal of shares (the "Redemption Procedure"). On 1 August 2024 the Company announced the outcome of the Redemption Procedure, which was later supplemented by additional information on the Company's website on 20 August 2024, where shareholders holding a total of 85,158,103 shares, corresponding to approximately 9.43% of the shares and votes in the Company, accepted and requested to redeem their shares. The Redemption Procedure was registered with the Swedish Companies Registration Office on 27 August 2024. Following the Redemption Procedure the ownership of the majority owners (HC Alliance Mining Group Ltd and Magomed Bazhaev) increased to approximately 93.0% of the shares and votes in the Company. In addition, one shareholder holding approximately 2.5% of the shares and votes in Kopy cooperates with the majority owners meaning that approximately 95.5% of the shares and votes is excluded from the free float calculation.

The Board of Directors of the Company considers that the functionality of the share pricing mechanism does not work in a satisfactory manner after the Redemption Procedure and the Company is in material non-compliance with Nasdaq First North's liquidity requirement, regarding shares in public ownership and the number of qualified investors.

In view of this, the Company's Board of Directors has resolved to request that the Company's shares are delisted from Nasdaq First North as soon as is practically possible.

The last day of trading in the Company's shares on Nasdaq First North will be announced in a separate press release as soon as the Company has received confirmation thereof from Nasdaq Stockholm AB.

This is a translation of the Swedish version of the press release. In case of discrepancies, the Swedish wording shall prevail.

For more information, please contact:

Mikhail Damrin, CEO, +7 916 808 12 17, mikhail.damrin@kopygoldfields.com
Erik Forsell, IR and Communication, erik.forsell@kopygoldfields.com

About Kopy Goldfields

Kopy Goldfields is a Swedish gold exploration and production company. Kopy Goldfields' strategy is to combine local geologic knowledge and science with international management, best industry practices and modern, efficient technology to identify and develop mineral deposits in a cost-efficient, safe and transparent way. Kopy Goldfields' shares are traded on Nasdaq First North Growth Market in Stockholm under the symbol "KOPY". Nordic Certified Advisers is Certified Adviser (Tel +46 707 94 90 73, e-mail: info@certifiedadviser.se).

This information is information that Kopy Goldfields is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-10-09 08:00 CEST.

© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.